1. Home
  2. CLDX vs EXPI Comparison

CLDX vs EXPI Comparison

Compare CLDX & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • EXPI
  • Stock Information
  • Founded
  • CLDX 1983
  • EXPI 2008
  • Country
  • CLDX United States
  • EXPI United States
  • Employees
  • CLDX N/A
  • EXPI N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • EXPI Real Estate
  • Sector
  • CLDX Health Care
  • EXPI Finance
  • Exchange
  • CLDX Nasdaq
  • EXPI Nasdaq
  • Market Cap
  • CLDX 1.6B
  • EXPI 1.8B
  • IPO Year
  • CLDX 2008
  • EXPI N/A
  • Fundamental
  • Price
  • CLDX $23.78
  • EXPI $11.23
  • Analyst Decision
  • CLDX Buy
  • EXPI Hold
  • Analyst Count
  • CLDX 7
  • EXPI 2
  • Target Price
  • CLDX $64.83
  • EXPI $13.50
  • AVG Volume (30 Days)
  • CLDX 1.1M
  • EXPI 1.5M
  • Earning Date
  • CLDX 02-24-2025
  • EXPI 02-20-2025
  • Dividend Yield
  • CLDX N/A
  • EXPI 1.78%
  • EPS Growth
  • CLDX N/A
  • EXPI N/A
  • EPS
  • CLDX N/A
  • EXPI N/A
  • Revenue
  • CLDX $9,976,000.00
  • EXPI $4,458,228,000.00
  • Revenue This Year
  • CLDX N/A
  • EXPI $7.24
  • Revenue Next Year
  • CLDX N/A
  • EXPI $7.69
  • P/E Ratio
  • CLDX N/A
  • EXPI N/A
  • Revenue Growth
  • CLDX 128.55
  • EXPI 5.50
  • 52 Week Low
  • CLDX $22.17
  • EXPI $8.91
  • 52 Week High
  • CLDX $53.18
  • EXPI $15.39
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 41.99
  • EXPI 42.38
  • Support Level
  • CLDX $22.17
  • EXPI $10.48
  • Resistance Level
  • CLDX $29.05
  • EXPI $11.70
  • Average True Range (ATR)
  • CLDX 1.57
  • EXPI 0.49
  • MACD
  • CLDX -0.26
  • EXPI 0.05
  • Stochastic Oscillator
  • CLDX 23.40
  • EXPI 50.71

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

Share on Social Networks: